Search

Your search keyword '"Perrouin‐Verbe, Marie‐Aimée"' showing total 264 results
Start Over Author "Perrouin‐Verbe, Marie‐Aimée"
264 results on '"Perrouin‐Verbe, Marie‐Aimée"'

3. Development of a predictive tool for sacral nerve modulation implantation in the treatment of non-obstructive urinary retention and/or slow urinary stream: a study from the Neuro-Urology Committee of the French Association of Urology

Author

Nasri, Jordan, Al Ashimi, Intisar, Tricard, Thibault, Fleury, Raphael, Matta, Imad, Bey, Elsa, Mesnard, Benoit, Gaillet, Sarah, Martin, Claire, Game, Xavier, Thuillier, Caroline, Chartier-Kastler, Emmanuel, Karsenty, Gilles, Perrouin-Verbe, Marie-Aimée, Demeestere, Amelie, Wagner, Laurent, Ruffion, Alain, Peyronnet, Benoit, Saussine, Christian, Phé, Véronique, Vermersch, Patrick, De Wachter, Stefan, and Biardeau, Xavier

Published
2023
Full Text
View/download PDF

4. Diagnosis and management of complications following pelvic organ prolapse surgery using a synthetic mesh: French national guidelines for clinical practice

Author

Deffieux, Xavier, Perrouin-Verbe, Marie-Aimée, Campagne-Loiseau, Sandrine, Donon, Laurence, Levesque, Amélie, Rigaud, Jérome, Stivalet, Nadja, Venara, Aurélien, Thubert, Thibault, Vidart, Adrien, Bosset, Pierre-Olivier, Revel-Delhom, Christine, Lucot, Jean-Philippe, and Hermieu, Jean François

Published
2024
Full Text
View/download PDF

7. Five-year Results from the Prospective, Multicenter, Observational SOUNDS Study of Patients with Overactive Bladder Treated with the InterStim System for Sacral Neuromodulation

Author

Chartier-Kastler, Emmanuel, Le Normand, Loïc, Ruffion, Alain, Saussine, Christian, Braguet, Raïssa, Rabut, Bertrand, Ragni, Evelyne, Perrouin-Verbe, Marie-Aimée, Pierrevelcin, Jean, Rousseau, Thierry, Gamé, Xavier, Tanneau, Yves, Dargent, François, Biardeau, Xavier, Graziana, Jean Pierre, Stoica, Gabriel, Brassart, Elena, Fourmarier, Marc, Yaghi, Najdat, Capon, Gregoire, Ferchaud, Jérôme, Berrogain, Nathalie, Peyrat, Laurence, Pecoux, François, Bryckaert, Pierre-Emmanuel, Karsenty, Gilles, Song, Shannon, Keller, David Urs Josef, and Cornu, Jean-Nicolas

Published
2023
Full Text
View/download PDF

12. Management of female pelvic organ prolapse—Summary of the 2021 HAS guidelines

Author

Pizzoferrato, Anne-Cécile, Thuillier, Caroline, Vénara, Aurélien, Bornsztein, Nicole, Bouquet, Sylvain, Cayrac, Mélanie, Cornillet-Bernard, Martine, Cotelle, Odile, Cour, Florence, Cretinon, Sophie, De Reilhac, Pia, Loriau, Jérôme, Pellet, Françoise, Perrouin-Verbe, Marie-Aimée, Pourcelot, Anne-Gaëlle, Revel-Delhom, Christine, Steenstrup, Benoit, Vogel, Thomas, Le Normand, Loïc, and Fritel, Xavier

Published
2023
Full Text
View/download PDF

13. A study of the immunohistochemical profile of bladder cancer in neuro-urological patients by the French Association of Urology

Author

Michel, Floriane, Cancrini, Fabiana, Cancel-Tassin, Géraldine, Gamé, Xavier, Huyghe, Eric, Rock, Aurélien, Léon, Grégoire, Uzan, Audrey, Desfemmes, François-Régis, Peyronnet, Benoît, Fallot, Jérémy, Léon, Priscilla, Rolland, Emmanuel, Perrouin-Verbe, Marie-Aimée, Wodey, Jacques, Capon, Grégoire, Karsenty, Gilles, Rouprêt, Morgan, Cussenot, Olivier, Alshehhi, Hussa, Comperat, Eva, and Phé, Véronique

Published
2022
Full Text
View/download PDF

14. Sacral Neuromodulation with the InterStim System for Overactive Bladder: 3-Year Results from the French Prospective, Multicenter, Observational SOUNDS Study

Author

Chartier-Kastler, Emmanuel, Normand, Loïc Le, Ruffion, Alain, Saussine, Christian, Braguet, Raïssa, Rabut, Bertrand, Ragni, Evelyne, Perrouin-Verbe, Marie-Aimée, Pierrevelcin, Jean, Rousseau, Thierry, Gamé, Xavier, Tanneau, Yves, Dargent, François, Biardeau, Xavier, Graziana, Jean Pierre, Stoica, Gabriel, Brassart, Elena, Fourmarier, Marc, Yaghi, Najdat, Capon, Gregoire, Ferchaud, Jérôme, Berrogain, Nathalie, Peyrat, Laurence, Pecoux, François, Bryckaert, Pierre-Emmanuel, Melotti, Alice, Abouihia, Abdallah, Keller, David Urs Josef, and Cornu, Jean-Nicolas

Published
2022
Full Text
View/download PDF

19. Impact of COVID-19 pandemic on functional urology procedures in France: a prospective study

Author

Guillot-Tantay, Cyrille, Robert, Grégoire, Ruffion, Alain, Gamé, Xavier, Balanca, Astrid, Cousin, Tiffany, Campello, Pierre-Vincent, Simon, Jeanne, Baron, Maximilien, Fleury, Raphael, Dequirez, Pierre-Luc, Davidson, Sypre, Joussain, Charles, Vangheluwe, Lucie, Anastay, Vassily, Léon, Priscilla, Perrouin-Verbe, Marie-Aimée, Peyronnet, Benoit, Biardeau, Xavier, Cornu, Jean-Nicolas, Karsenty, Gilles, and Phé, Véronique

Published
2022
Full Text
View/download PDF

20. Prioritization of risk situations in neuro-urology: guidelines from Association Française d’Urologie (AFU), Association Francophone Internationale des Groupes d’Animation de la Paraplégie (A.F.I.G.A.P.), Groupe de Neuro-urologie de Langue Française (GENULF), Société Française de Médecine Physique et de Réadaptation (SOFMER) and Société Interdisciplinaire Francophone d’UroDynamique et de Pelvi-Périnéologie (SIFUD-PP)

Author

Hentzen, Claire, Biardeau, Xavier, Turmel, Nicolas, Haddad, Rebecca, Bey, Elsa, Amarenco, Gérard, Denys, Pierre, Phé, Véronique, Perrouin-Verbe, Marie Aimée, Peyronnet, Benoit, and Joussain, Charles

Published
2022
Full Text
View/download PDF

24. Could a better understanding of the underlying pathophysiologies lead to more informed treatment choices in patients with lower urinary tract dysfunction due to an acontractile or underactive detrusor? ICI‐RS 2023.

Author

Sinha, Sanjay, Everaert, Karel, Kheir, George Bou, Roberts, Neil, Solomon, Eskinder, Belal, Mohammed, Selai, Caroline, Perrouin‐Verbe, Marie‐Aimée, Spicchiale, Claudia Fede, Wein, Alan, and Abrams, Paul

Subjects
URINARY organs, BIOMARKERS, URODYNAMICS, URINATION disorders, BLADDER
Abstract

Introduction: The underlying pathophysiology behind a diagnosis of acontractile or underactive detrusor at invasive urodynamics is very heterogeneous. Lack of etiological classification currently limits the possibility of stratifying therapy. Methods: This subject was discussed at a think‐tank on the subject at the International Consultation on Incontinence‐Research Society held in Bristol, June 2023. This manuscript is a result of those deliberations and the subsequent discussions of the think‐tank. Results: There are challenges in defining abnormalities of detrusor contraction with resultant implications for available evidence. Pathology at any level of the neuromuscular pathway can impair or prevent a detrusor voiding contraction. Attempts have been made to identify clinical markers that might predict an underactive detrusor but strong supporting evidence is lacking. Hence, a holistic approach to phenotyping requires specialized neuro‐imaging as well as physiological investigations. Several general measures can help individuals with an abnormal detrusor contraction. The search for a molecule to enhance the detrusor voiding contraction remains elusive but there are promising new candidates. Neuromodulation can help select individuals but data is not well stratified by underlying etiology. Manipulation of central neurotransmitters might offer an alternate therapeutic option. Conclusions: A better understanding of the underlying pathophysiologies behind an abnormality of the detrusor voiding contraction is needed for improving management. Towards this goal, the think‐tank proposes a classification of the underactive detrusor that might help in selecting and reporting more well‐defined patient cohorts. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

25. Developing new ways to assess neural control of pelvic organ function in spinal conditions: ICI‐RS 2023.

Author

Webb, Katie, de Rijk, Mathijs M., Gajewski, Jerzy B., Kanai, Anthony J., Perrouin‐Verbe, Marie‐Aimée, van Koeveringe, Gommert, Wyndaele, Jean‐Jacques, and Drake, Marcus J.

Subjects
CORTI'S organ, MEDICAL sciences, CENTRAL nervous system, SPINAL cord, URINARY organs
Abstract

Objectives: Several central nervous system (CNS) centers affect muscle groups of the lower urinary tract (LUT) and anorectal tract (ART) via autonomic and somatic pathways, working in different modes (storage or expulsion). Hence spinal cord dysfunction can affect the LUT and ART by several possible mechanisms. Methods: This review reports the discussions of a workshop at the 2023 meeting of the International Consultation on Incontinence Research Society, which reviewed uncertainties and research priorities of spinal dysfunction. Results: Discussion focussed on the levator ani nerve, mechanisms underpinning sensory function and sensation, functional imaging, dyssynergia, and experimental models. The following key research questions were identified. (1) Clinically, how can we evaluate the levator ani muscle to support assessment and identify prognosis for effective treatment selection? (2) How can we reliably measure levator ani tone? (3) How can we evaluate sensory information and sensation for the LUT and the ART? (4) What is the role of functional CNS imaging in development of scientific insights and clinical evaluation? (5) What is the relationship of detrusor sphincter dyssynergia to renal failure? Conclusions: Spinal cord dysfunction can fundamentally disrupt LUT and ART function, with considerable clinical impact. The evaluation needs to reflect the full scope of potential problems, and new clinical and diagnostic approaches are needed, for prognosis and treatment. The preclinical science evaluating spinal cord function in both LUT and ART storage and elimination remains a major priority, even though it is a challenging experimental context. Without this underpinning evidence, development of new clinical evidence may be held back. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

29. Robot-assisted laparoscopic continent cutaneous urinary diversion in a single- center study; surgical technique and outcomes

Author

Loubersac, Thomas, primary, Lavallée, Etienne, additional, Reiss, Benedicte, additional, Lefort, Marc, additional, Kieny, Pierre, additional, Leclair, Marc-David, additional, Rigaud, Jérôme, additional, Normand, Loic Le, additional, Perrouin-Verbe, Brigitte, additional, Lefevre, Chloe, additional, and Perrouin-Verbe, Marie-aimée, additional

Published
2023
Full Text
View/download PDF

30. Could a better understanding of the underlying pathophysiologies lead to more informed treatment choices in patients with lower urinary tract dysfunction due to an acontractile or underactive detrusor? ICI‐RS 2023

Author

Sinha, Sanjay, primary, Everaert, Karel, additional, Kheir, George Bou, additional, Roberts, Neil, additional, Solomon, Eskinder, additional, Belal, Mohammed, additional, Selai, Caroline, additional, Perrouin‐Verbe, Marie‐Aimée, additional, Spicchiale, Claudia Fede, additional, Wein, Alan, additional, and Abrams, Paul, additional

Published
2023
Full Text
View/download PDF

31. Recommandations sur la gestion du risque et la prise en charge urologique du patient adulte atteint de dysraphisme spinal (spina bifida)

Author

Manunta, Andréa, Peyronnet, Benoît, Olivari-Philiponnet, Camille, Chartier-Kastler, Emmanuel J., Saussine, Christian C., Phé, Véronique, Robain, Gilberte, Denys, Pierre, Even, Alexia, Samson, Emmanuelle, Grise, Phillippe, Karsenty, G., Hascoet, Juliette, Castel-Lacanal, Evelyne, Charvier, Kathleen F., Guinet-Lacoste, Amandine, Chesnel, Camille, Amarenco, Gérard, Haffner, F., Haddad, Mirna, Le Normand, Loïc, Perrouin-Verbe, Marie Aimée, Perrouin-Verbe, Brigitte, de Seze, Marianne, Ruffion, Alain, Gamé, Xavier, CHU Pontchaillou [Rennes], CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Sorbonne Université (SU), Hôpital Raymond Poincaré [Garches], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), CHU Strasbourg, CHU Tenon [AP-HP], Université de Versailles Saint-Quentin-en-Yvelines - UFR Sciences de la santé Simone Veil (UVSQ Santé), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), CHU Rouen, Normandie Université (NU), Chirurgie urologique et transplantation rénale [Hôpital de la Conception - APHM], Aix Marseille Université (AMU)-Assistance Publique - Hôpitaux de Marseille (APHM)-Hôpital de la Conception [CHU - APHM] (LA CONCEPTION), Service Médecine physique et de réadaptation [CHU Toulouse], Pôle Neurosciences [CHU Toulouse], Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Pôle Santé publique et médecine publique [CHU Toulouse], Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Médecine Physique et Réadaptation [Hôpital Henry Gabrielle - Lyon], Hôpital Henry Gabrielle [CHU - HCL], Hospices Civils de Lyon (HCL)-Hospices Civils de Lyon (HCL), Groupe de RecherchE CliniquE en Neuro-urologie [CHU Tenon] (GRC 1 - GREEN ), CHU Marseille, Centre hospitalier universitaire de Nantes (CHU Nantes), Clinique Saint Augustin, and Hospices Civils de Lyon (HCL)

Subjects
Quality of life, Complications, [SDV]Life Sciences [q-bio], Urology, Urinary incontinence, Neurogenic, Spinal dysraphism, Spina bifida, Urinary bladder
Abstract

International audience; Introduction: Improved life expectancy and prenatal screening have changed the demographics of spina bifida (spinal dysraphism) which has presently become a disease of adulthood. Urinary disorders affect almost all patients with spinal dysraphism and are still the leading cause of mortality in these patients. The aim of this work was to establish recommendations for urological management that take into account the specificities of the spina bifida population. Materials and methods: National Diagnosis and Management Guidelines (PNDS) were drafted within the framework of the French Rare Diseases Plan at the initiative of the Centre de Référence Maladies Rares Spina Bifida - Dysraphismes of Rennes University Hospital. It is a collaborative work involving experts from different specialties, mainly urologists and rehabilitation physicians. We conducted a systematic search of the literature in French and English in the various fields covered by these recommendations in the MEDLINE database. In accordance with the methodology recommended by the authorities (Guide_methodologique_pnds.pdf, 2006), proposed recommendations were drafted on the basis of this literature review and then submitted to a review group until a consensus was reached. Results: Bladder dysfunctions induced by spinal dysraphism are multiple and varied and evolve over time. Management must be individually adapted and take into account all the patient's problems, and is therefore necessarily multi-disciplinary. Self-catheterisation is the appropriate micturition method for more than half of the patients and must sometimes be combined with treatments aimed at suppressing any neurogenic detrusor overactivity (NDO) or compliance alteration (anticholinergics, intra-detrusor botulinum toxin). Resort to surgery is sometimes necessary either after failure of non-invasive treatments (e.g. bladder augmentation in case of NDO resistant to pharmacological treatment), or as a first line treatment in the absence of other non-invasive alternatives (e.g. aponeurotic suburethral tape or artificial urinary sphincter for sphincter insufficiency; urinary diversion by ileal conduit if self-catheterisation is impossible). Conclusion: Spinal dysraphism is a complex pathology with multiple neurological, orthopedic, gastrointestinal and urological involvement. The management of bladder and bowel dysfunctions must continue throughout the life of these patients and must be integrated into a multidisciplinary context.

Published
2023

32. Intradetrusor Injections of Botulinum Toxin A in Adults with Spinal Dysraphism

Author

Peyronnet, Benoit, Even, Alexia, Capon, Grégoire, De Seze, Marianne, Hascoet, Juliette, Biardeau, Xavier, Baron, Maximilien, Perrouin-Verbe, Marie-Aimée, Boutin, Jean-Michel, Saussine, Christian, Phé, Véronique, Lenormand, Loic, Chartier-Kastler, Emmanuel, Cornu, Jean-Nicolas, Karsenty, Gilles, Manunta, Andrea, Schurch, Brigitte, Denys, Pierre, Amarenco, Gérard, and Game, Xavier

Published
2018
Full Text
View/download PDF

33. Fatty acid profile in peri-prostatic adipose tissue and prostate cancer aggressiveness in African–Caribbean and Caucasian patients

Author

Figiel, Sandy, Pinault, Michelle, Domingo, Isabelle, Guimaraes, Cyrille, Guibon, Roseline, Besson, Pierre, Tavernier, Elsa, Blanchet, Pascal, Multigner, Luc, Bruyère, Franck, Haillot, Olivier, Mathieu, Romain, Vincendeau, Sebastien, Rioux-Leclercq, Nathalie, Lebdai, Souhil, Azzouzi, Abdel-Rahmene, Perrouin-Verbe, Marie-Aimee, Fournier, Georges, Doucet, Laurent, Rigaud, Jerome, Renaudin, Karine, Mahéo, Karine, and Fromont, Gaëlle

Published
2018
Full Text
View/download PDF

36. Response to tibial and sacral nerve modulation in overactive bladder: Is there any correlation?

Author

Fourel, Mathieu, Hafez, Samy, Ramdane, Nassima, Perrouin‐Verbe, Marie‐Aimée, De Wachter, Stefan, Vermersch, Patrick, and Biardeau, Xavier

Subjects
SACRAL nerves, OVERACTIVE bladder, TIBIAL nerve, TRANSCUTANEOUS electrical nerve stimulation, STATISTICAL correlation
Abstract

Objectives: To assess the correlation between the response to transcutaneous tibial nerve stimulation (TTNS) and subsequent response to sacral nerve modulation (SNM) to treat overactive bladder (OAB). Materials and Methods: All patients who consecutively received TTNS followed by a two‐stage SNM between January 2016 and June 2022 to treat OAB in two university hospital centers were included. The response to each therapy was evaluated with success defined by a 50% or greater improvement in one or more bothersome urinary symptoms from baseline. The primary endpoint was the statistical relationship between the response to TTNS and the response to SNM, assessed by logistic regression. Secondary endpoints were the statistical relationship between the response to TTNS and the response to SNM when controlling for gender, age (<57 years vs. >57 years), presence of an underlying neurological disease, and presence of DO, adding the factor and interaction to the previous regression model. Results: Among the 92 patients enrolled in the study, 68 of them were women (73.9%), and the median age was 57.0 [41.0–69.0] years. The success was reported in 22 patients (23.9%) under TTNS and 66 patients (71.7%) during the SNM test phase. There was no statistical correlation between response to TTNS and response to SNM in the overall population (confidence interval: 95% [0.48–4.47], p = 0.51). Similarly, there was no statistical correlation when controlling for age <57 years or ≥57 years, with p = 1.0 and p = 0.69, respectively. No statistical study could be conducted for the other subpopulations due to small sample sizes. Conclusion: The response to TTNS does not predict the response to SNM in the treatment of OAB. TTNS and SNM should be considered as separate therapies, and the decision‐making process for OAB treatment should take this into account. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

37. Intravesical injections of botulinum neurotoxin A to treat overactive bladder and/or detrusor overactivity related to multiple sclerosis: 5-Year continuation rate and specific risk factors for discontinuation—A study from the neuro-urology committee of the French Association of Urology

Author

Delaval, Stéphanie, Dequirez, Pierre-Luc, Hentzen, Claire, Baron, Maximilien, Mille, Eva, Tariel, François, Peyronnet, Benoit, Perrouin-Verbe, Marie-Aimée, Pierache, Adeline, Chartier-Kastler, Emmanuel, Capon, Grégoire, Cornu, Jean-Nicolas, Castel-Lacanal, Evelyne, Gamé, Xavier, Karsenty, Gilles, Ruffion, Alain, Denys, Pierre, Even, Alexia, Amarenco, Gérard, Phé, Véronique, Biardeau, Xavier, Joussain, Charles, Service d'Urologie, andrologie et transplantation rénale [CHRU Lille], Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), CHU Tenon [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Centre hospitalier universitaire de Nantes (CHU Nantes), Hôpital de la Conception [CHU - APHM] (LA CONCEPTION), Service d'urologie [Rennes] = Urology [Rennes], Hôpital Pontchaillou-CHU Pontchaillou [Rennes], CHU Lille, CHU Pitié-Salpêtrière [AP-HP], service d'urologie [CHU Bordeaux], CHU Bordeaux [Bordeaux], Service d'urologie [Rouen], CHU Rouen, Normandie Université (NU)-Normandie Université (NU)-Université de Rouen Normandie (UNIROUEN), Normandie Université (NU), Nutrition, Inflammation et axe Microbiote-Intestin-Cerveau (ADEN), Université de Rouen Normandie (UNIROUEN), Normandie Université (NU)-Normandie Université (NU)-Institute for Research and Innovation in Biomedicine (IRIB), Normandie Université (NU)-Normandie Université (NU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université de Rouen Normandie (UNIROUEN), Normandie Université (NU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institute for Research and Innovation in Biomedicine (IRIB), Normandie Université (NU)-Normandie Université (NU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Service Médecine physique et de réadaptation [CHU Toulouse], Pôle Neurosciences [CHU Toulouse], Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Pôle Santé publique et médecine publique [CHU Toulouse], Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Pôle Urologie - Néphrologie - Dialyse - Transplantations - Brûlés - Chirurgie plastique - Explorations fonctionnelles et physiologiques [CHU Toulouse], Hospices Civils de Lyon (HCL), Hôpital Raymond Poincaré [AP-HP], Handicap neuromusculaire : Physiopathologie, Biothérapie et Pharmacologies appliquées (END-ICAP), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Institut National de la Santé et de la Recherche Médicale (INSERM), Lille Neurosciences & Cognition - U 1172 (LilNCog), and Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)

Subjects
[SDV]Life Sciences [q-bio]
Abstract

Background: While intravesical injections of botulinum neurotoxin A (BoNT-A) are currently recommended for patients experiencing refractory neurogenic overactive bladder and/or detrusor overactivity (OAB/DO), it is unclear how much this therapy is effective and sustainable in the long-term in patients with multiple sclerosis (MS). Objectives: To assess the mid-term continuation rate of BoNT-A injections to treat neurogenic OAB/DO in MS patients and to investigate MS-specific risk factors for discontinuation. Methods: This retrospective study involved 11 French university hospital centers. All MS patients who received BoNT-A to treat neurogenic OAB/DO between 2008 and 2013 and were subsequently followed up for at least 5 years were eligible. Results: Of the 196 MS patients included, 159 (81.1%) were still under BoNT-A 5 years after the first injection. The combination of the Expanded Disability Status Scale (EDSS < 6 or ⩾ 6) and of the MS type (relapsing–remitting vs progressive) predicted the risk of discontinuation. This risk was 5.5% for patients with no risk factor, whereas patients presenting with one or two risk factors were 3.3 and 5.7 times more likely to discontinue, respectively. Conclusion: BoNT-A is a satisfying mid-term neurogenic OAB/DO therapy for most MS patients. Combining EDSS and MS type could help predict BoNT-A discontinuation.

Published
2023

41. Robot‐assisted laparoscopic cystectomy with non‐continent urinary diversion for neurogenic lower urinary tract dysfunction: Midterm outcomes

Author

Calën, Laura, primary, Mesnard, Benoît, additional, Hedhli, Oussama, additional, Broudeur, Lucas, additional, Reiss, Bénédicte, additional, Loubersac, Thomas, additional, Branchereau, Julien, additional, Baron, Maximilien, additional, Rigaud, Jérôme, additional, Le fort, Marc, additional, Perrouin‐Verbe, Brigitte, additional, Le Normand, Loïc, additional, Lefevre, Chloé, additional, and Perrouin‐Verbe, Marie‐Aimée, additional

Published
2023
Full Text
View/download PDF

45. Adjustable Continence Therapy (ACT®) balloons to treat female stress urinary incontinence: effectiveness, safety and risk factors of failure and complication

Author

de Guerry, Marie-Liesse, primary, Demeestere, Amélie, additional, Bergot, Christophe, additional, de Hauteclocque, Astrid, additional, Hascoet, Juliette, additional, Bajeot, Anne-Sophie, additional, Ternynck, Camille, additional, Gamé, Xavier, additional, Peyronnet, Benoît, additional, Capon, Grégoire, additional, Perrouin-Verbe, Marie-Aimée, additional, and Biardeau, Xavier, additional

Published
2022
Full Text
View/download PDF

48. MP18-10 EVALUATION OF CLINICAL PERFORMANCE AND SAFETY FOR THE RECHARGEABLE INTERSTIM TM MICRO IN OVERACTIVE BLADDER SUBJECTS: 3-MONTH RESULTS FROM THE GLOBAL POST-MARKET ELITE STUDY

Author

Xavier, Keith, primary, Goudelocke, Colin, additional, Pecha, Barry, additional, Burgess, Kimberly, additional, Perrouin-Verbe, Marie-Aimée, additional, Krlin, Ryan, additional, Michaels, Jodi, additional, Shah, Sagar, additional, Peyronnet, Benoît, additional, Zaslau, Stanley, additional, Papi, Bianca, additional, Bittner, Katie, additional, Elterman, Dean, additional, and Nitti, Victor, additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results